Tissue adaptation of CD4 T lymphocytes in homeostasis and cancer

The immune system is traditionally classified as a defense system that can discriminate between self and non-self or dangerous and non-dangerous situations, unleashing a tolerogenic reaction or immune response. These activities are mainly coordinated by the interaction between innate and adaptive cells that act together to eliminate harmful stimuli and keep tissue healthy. However, healthy tissue is not always the end point of an immune response. Much evidence has been accumulated over the years, showing that the immune system has complex, diversified, and integrated functions that converge to maintaining tissue homeostasis, even in the absence of aggression, interacting with the tissue cells and allowing the functional maintenance of that tissue. One of the main cells known for their function in helping the immune response through the production of cytokines is CD4+ T lymphocytes. The cytokines produced by the different subtypes act not only on immune cells but also on tissue cells. Considering that tissues have specific mediators in their architecture, it is plausible that the presence and frequency of CD4+ T lymphocytes of specific subtypes (Th1, Th2, Th17, and others) maintain tissue homeostasis. In situations where homeostasis is disrupted, such as infections, allergies, inflammatory processes, and cancer, local CD4+ T lymphocytes respond to this disruption and, as in the healthy tissue, towards the equilibrium of tissue dynamics. CD4+ T lymphocytes can be manipulated by tumor cells to promote tumor development and metastasis, making them a prognostic factor in various types of cancer. Therefore, understanding the function of tissue-specific CD4+ T lymphocytes is essential in developing new strategies for treating tissue-specific diseases, as occurs in cancer. In this context, this article reviews the evidence for this hypothesis regarding the phenotypes and functions of CD4+ T lymphocytes and compares their contribution to maintaining tissue homeostasis in different organs in a steady state and during tumor progression

Effectiveness of laughter therapy on anxiety and depression in hospitalized patients: a systematic review and meta-analysis

Objective: To verify the effectiveness of laughter therapy on anxiety and depression in hospitalized patients. Methods: A systematic review of experimental studies and quasi-experimental studies was carried out after being registered in the PROSPERO database (CRD42020138934). The search was performed in September 2022 in PubMed, Web of Science, Lilacs, Cochrane Library and Scopus. Inclusion criteria were: a) hospitalized patients who experienced anxiety or depression and who underwent at least one session of laughter therapy, b) studies with outcomes of laughter therapy on anxiety and depression. The studies were selected in two stages: by reading the titles and abstracts of the studies, and by reading the full papers that met the eligibility criteria. The risk of bias of the studies was assessed using the RoB 2 and ROBINS-I tools. The quality of the evidence synthesis was measured by GRADE. Results: 4,472 studies were found and 15 of them were included. Laughter therapy was shown to be effective in reducing anxiety and depression in both hospitalized children and adults. Ten were randomized controlled trials (nine of them were at high risk of bias) and five were quasi-experimental studies. Meta-analysis showed significant improvement in anxiety (mean difference = -10.55, 95% CI: -19.97, -1.14, p 0.03, I² = 84%) and depression (mean difference = -2.43, 95% CI: -3.63, -1.24, p <0.0001, I² =0%). Conclusion: According to the findings of this study, it was verified that laughter therapy seems to be more effective than standard care for reducing anxiety and depression in hospitalized patients. However, further studies with low risk of bias are required

A New Mouse Model for Marfan Syndrome Presents Phenotypic Variability Associated with the Genetic Background and Overall Levels of Fbn1 Expression

Marfan syndrome is an autosomal dominant disease of connective tissue caused by mutations in the fibrillin-1 encoding gene FBN1. Patients present cardiovascular, ocular and skeletal manifestations, and although being fully penetrant, MFS is characterized by a wide clinical variability both within and between families. Here we describe a new mouse model of MFS that recapitulates the clinical heterogeneity of the syndrome in humans. Heterozygotes for the mutant Fbn1 allele mgΔloxPneo, carrying the same internal deletion of exons 19–24 as the mgΔ mouse model, present defective microfibrillar deposition, emphysema, deterioration of aortic wall and kyphosis. However, the onset of a clinical phenotypes is earlier in the 129/Sv than in C57BL/6 background, indicating the existence of genetic modifiers of MFS between these two mouse strains. In addition, we characterized a wide clinical variability within the 129/Sv congenic heterozygotes, suggesting involvement of epigenetic factors in disease severity. Finally, we show a strong negative correlation between overall levels of Fbn1 expression and the severity of the phenotypes, corroborating the suggested protective role of normal fibrillin-1 in MFS pathogenesis, and supporting the development of therapies based on increasing Fbn1 expression

Improving additive manufacturing performance by build orientation optimization

Additive manufacturing (AM) is an emerging type of production technology to create three-dimensional objects layer-by-layer directly from a 3D CAD model. AM is being extensively used in several areas by engineers and designers. Build orientation is a critical issue in AM since it is associated with the part accuracy, the number of supports required and the processing time to produce the object. This paper presents an optimization approach to solve the part build orientation problem taking into account some characteristics or measures that can affect the accuracy of the part, namely the volumetric error, the support area, the staircase effect, the build time, the surface roughness and the surface quality. A global optimization method, the Electromagnetism-like algorithm, is used to solve the part build orientation problem.The authors are grateful to the anonymous referees for their fruitfulcomments and suggestions. This work has been supported and developed under the FIBR3Dproject - Hybrid processes based on additive manufacturing of composites with long or shortfibers reinforced thermoplastic matrix (POCI-01-0145-FEDER-016414), supported by theLisbon Regional Operational Programme 2020, under the PORTUGAL 2020 PartnershipAgreement, through the European Regional Development Fund (ERDF). This work hasbeen also supported by national funds through FCT - Funda ̧c ̃ao para a Ciˆencia e Tecnologiawithin the Project Scope: UID/CEC/00319/201

Genomic and molecular analyses identify molecular subtypes of pancreatic cancer recurrence

Pancreatic cancer (PC) remains a highly lethal malignancy, and most patients with localized disease that undergo surgical resection still succumb to recurrent disease. Pattern of recurrence after pancreatectomy is heterogenous, with some studies illustrating that site of recurrence can be associated with prognosis.1 Another study suggested that tumors that develop local and distant recurrence can be regarded as a homogenous disease with similar outcomes.2 Here we investigate novel molecular determinants of recurrence pattern after pancreatectomy for PC

Patterns of HIV-1 Protein Interaction Identify Perturbed Host-Cellular Subsystems

Human immunodeficiency virus type 1 (HIV-1) exploits a diverse array of host cell functions in order to replicate. This is mediated through a network of virus-host interactions. A variety of recent studies have catalogued this information. In particular the HIV-1, Human Protein Interaction Database (HHPID) has provided a unique depth of protein interaction detail. However, as a map of HIV-1 infection, the HHPID is problematic, as it contains curation error and redundancy; in addition, it is based on a heterogeneous set of experimental methods. Based on identifying shared patterns of HIV-host interaction, we have developed a novel methodology to delimit the core set of host-cellular functions and their associated perturbation from the HHPID. Initially, using biclustering, we identify 279 significant sets of host proteins that undergo the same types of interaction. The functional cohesiveness of these protein sets was validated using a human protein-protein interaction network, gene ontology annotation and sequence similarity. Next, using a distance measure, we group host protein sets and identify 37 distinct higher-level subsystems. We further demonstrate the biological significance of these subsystems by cross-referencing with global siRNA screens that have been used to detect host factors necessary for HIV-1 replication, and investigate the seemingly small intersect between these data sets. Our results highlight significant host-cell subsystems that are perturbed during the course of HIV-1 infection. Moreover, we characterise the patterns of interaction that contribute to these perturbations. Thus, our work disentangles the complex set of HIV-1-host protein interactions in the HHPID, reconciles these with siRNA screens and provides an accessible and interpretable map of infection